AzTrials
AzTrials

Cardiovascular ShockNCT03753672

Central Venous Pressure (CVP) Changes do Not Predict Preload Unresponsiveness

An observational study of Cardiovascular Shock, run by Hopital Antoine Beclere at 1 site in France.

Unknown status

Status not confirmed. The sponsor has not verified this record for over two years, so it may be out of date.

Official record
Search all trials

Trial summary

Passive leg raising (PLR) is routinely used to predict preload responsiveness in critically ill patients. However, real-time measurements of cardiac output are required to assess its effects. Some authors have suggested that in fluid non-responders, central venous pressure (CVP) increased markedly. Read more about this study

Who is it for?
Any age
Conditions the study is for
Cardiovascular Shock
What is being tested?
preload responsiveness
How many people
45 participants
Where
1 siteFrance
Study dates
10 Dec 2017to Jun 2019
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Study population: Critically ill patients with a central venous catheter in place and for whom the physician decided to test preload responsiveness by PLR were prospectively included. Transthoracic echocardiography was performed to obtain VTI. The CVP and VTI were measured before and during PLR.

Who may be able to join

  • ADULTS
  • Patients presenting with shock or other signs of circulatory failure (tachycardia, oliguria)
  • Need for the physician to test preload responsiveness
  • Patients already equipped by a central venous catheter for the measurement of CVP

Who cannot join

  • patients<18 years old
  • pregnancy
  • instaility justifying rapid increase in cathecolamines

Trial locations and contacts

1 site in 1 country.

France1 site, 1 recruiting
  • Hamzaoui Olfa

    Clamart, 92141

    OLFA HAMZAOUI, MD, 0033145374957, olfa.hamzaoui@abc.aphp.fr

    Recruiting

Other trials in France

About this study

Passive leg raising (PLR) is routinely used to predict preload responsiveness in critically ill patients. However, real-time measurements of cardiac output are required to assess its effects. Some authors have suggested that in fluid non-responders, central venous pressure (CVP) increased markedly. By analogy with the CVP rules proposed by Weill et al to assess a fluid challenge, it has been hypothesized that an increase in CVP ≥ 5 mmHg during PLR can predict preload unresponsiveness.

Objective Investigation of whether an increase in CVP ≥ 5 mmHg during PLR predict preload unresponsiveness diagnosed by the absence of increase in velocity-time integral (VTI) of the flow in the left ventricular outflow tract by more than 10% (4).

Methods Critically ill patients with a central venous catheter in place and for whom the physician decided to test preload responsiveness by PLR were prospectively included. Transthoracic echocardiography was performed to obtain VTI. The CVP and VTI were measured before and during PLR.

Being tested
preload responsiveness
Medical subject headings
Shock, Cardiogenic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • preload responsivenessDiagnostic test

    We investigated whether an increase in CVP ≥ 5 mmHg during PLR predict preload unresponsiveness diagnosed by the absence of increase in velocity-time integral (VTI) of the flow in the left ventricular outflow tract by more than 10%

Study groups in NCT03753672
Study groupRoleWhat they receive
preload responsivedefined as an increase in Velocity time integral of the sub-aortic flow greater or equal to 10%
Receives: Diagnostic Test: preload responsiveness
preload unresponsivedefined as an increase in Velocity time integral of the sub-aortic flow lower than 10%
Receives: Diagnostic Test: preload responsiveness

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. the predictive value of changes in CVP to determine preload responsiveness

    Systolic, diastolic and mean arterial pressure will be assessed before and after the PLR test

    Measured: ONE MINUTE TEST

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted27 Nov 2018
  2. Study start10 Dec 2017
  3. Primary completionMar 2019 (estimated)
  4. Study completionJun 2019 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Cohort
Time perspective
Prospective
Enrolment
45 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT03753672
Sponsor's protocol ID
2017-A03578-45
Status last verified
Feb 2019
First submitted
19 Nov 2018
Last updated
22 Feb 2019
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Undecided

Publications

  • Hamzaoui O, Gouezel C, Jozwiak M, Millereux M, Sztrymf B, Prat D, Jacobs F, Monnet X, Trouiller P, Teboul JL. Increase in Central Venous Pressure During Passive Leg Raising Cannot Detect Preload Unresponsiveness. Crit Care Med. 2020 Aug;48(8):e684-e689. doi: 10.1097/CCM.0000000000004414.

    PubMed 32697509

Questions about this trial

What is this clinical trial studying?

An observational study of Cardiovascular Shock, run by Hopital Antoine Beclere at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: status not confirmed, as of the sponsor's last update on 22 Feb 2019. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

Each site lists its own contact: choose the nearest one under Trial locations. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

the predictive value of changes in CVP to determine preload responsiveness (time frame: ONE MINUTE TEST). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT03753672, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Feb 2019; AzTrials last refreshed its copy on 30 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in